Close Menu
    Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Contracts + Grants

    DRIVe: Accelerating National Health Security Innovation

    By Stephanie LizotteApril 29, 2018
    Biomedical Countermeasures
    Share
    Facebook LinkedIn Reddit Email

    The Biomedical Advanced Research and Development Authority (BARDA), Division of Research, Innovation and Ventures (DRIVe) is seeking applicants interested in working with BARDA DRIVe as part of a network of accelerators across America to promote national health security innovation.

    The DRIVe Accelerator Network will leverage key regional hubs where health security products and technologies in biotechnology, life science research, and medical innovations are most heavily occurring, and will increase the growth potential in other regions across the US.

    The Accelerator Network aims to:

    • Support BARDA DRIVe health security products and technologies as they navigate research, development, and regulatory pathways
    • Provide services to assist R&D efforts (technical advice, access to facilities and incubator spaces, integration services)
    • Identify and foster innovations in early health security product and technology development
    • Cultivate the community of those making a difference in health security products, technologies and innovations

    The goal will be to populate the R&D pipeline with candidate health security products and technologies that are ready to advance to later-stage funding outside of the accelerator network for clinical development and commercialization, to revolutionize our capability and capacity for national health security preparedness and response.

    Further details are available via Funding Opportunity Number: EP-IDS-18-001. Applications are due May 17, 2018.

    Sources: FBO.gov, Grants.gov, Phe.gov

    Read also:

    •  Combating Antibiotic Resistant Bacteria (CARB) Biopharmaceutical Accelerator
    ASPR BARDA HHS RFI
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleHealth and Human Services Biodefense Budget Oversight
    Next Article Anti-Ricin Monoclonal Antibody Licensed for Development

    Related Stories

    First Light Diagnostics Receives FDA Clearance for Rapid Anthrax Test

    December 5, 2023

    ARPA-H Announces New Tiered Proposal Submission System to Reduce Applicant Barriers

    December 5, 2023

    Needle-Free Vaccine Patch Against Zika Virus

    December 2, 2023

    Inflammatix Completes Development for Acute Infection and Sepsis Test System

    November 15, 2023
    News Scan

    Biodefense Headlines – 30 November 2023

    News Scan November 30, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include the largest ever outbreak of mpox in the DRC; launch of National Wastewater Surveillance Program dashboard; low uptake of COVID-19 boosters and flu vaccines;…

    Upcoming Events

    Mar 12
    Hybrid Hybrid Event
    March 12, 2024 - March 17, 2024

    2024 Fungal Genetics Conference

    Mar 21
    March 21, 2024 - March 23, 2024

    ASPPH 2024 Annual Meeting

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    News on pathogens and preparedness for public health emergencies

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.

    Global Biodefense places cookies on your device to enable the best user experience. By using our website, you agree to placement of these cookies. To learn more, read our Privacy Policy.OKPrivacy Policy